PRAGUE, Czechia—The number of people taking loop diuretics without a diagnosis of heart failure (HF) may be many times higher than the number of HF patients on these meds, according to an analysis of ...
To earn CME related to this news article, click here. January 28, 2009 — Prolonged use, but not ever-use, of loop diuretics is linked to a higher fracture risk in postmenopausal women, according to ...
Semaglutide — a type of medication used to treat diabetes and can help with weight loss — reduces the need for loop diuretics and dose, and has positive effects on heart failure symptoms, physical ...
Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...
People with heart failure are often prescribed what are known as loop diuretic medications to help reduce the fluid buildup that's a hallmark of the disease. Now, research suggests that taking the ...
The use of loop diuretics does not appear to be associated with changes in bone mineral density, falls or fractures in postmenopausal women, according to a report in the January 26 issue of Archives ...
In a meta-analysis, researchers found no difference in all-cause mortality for intensive-care patients with fluid overload who were treated with loop diuretics, compared with those given a placebo or ...
Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...
Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual ...
Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...
Please provide your email address to receive an email when new articles are posted on . Compared with placebo, Wegovy improved HF symptoms and physical limitations in patients with obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results